Gerresheimer AG has initiated the sale of its US subsidiary, Centor Inc., as part of a strategic effort to optimize its capital structure and enhance focus on its core competencies in the pharmaceutical and cosmetics sectors.

Information on the target

Gerresheimer AG is a leading global partner and innovative system and solution provider for the pharmaceutical, biotech, and cosmetics industries. The company specializes in offering a comprehensive portfolio of drug containment solutions, including closures, accessories, drug delivery systems, and medical devices. With a strong commitment to quality and sustainability, Gerresheimer operates over 40 production sites across 16 countries, ensuring that its products meet the diverse needs of regional markets.

Recently, Gerresheimer has announced the initiation of the sale of its US subsidiary, Centor Inc., which specializes in packaging systems for dispensing prescription drugs. This strategic move is part of the company's broader effort to optimize its capital and financing structure while continuing to implement its transformation program aimed at achieving profitable growth.

Industry overview in the target’s specific country

The pharmaceutical and cosmetics industries in the United States are characterized by robust growth and innovation, driven by increasing demand for advanced healthcare solutions and sustainable products. The market is influenced by a combination of factors, i